Factors associated with the interruption of antiretroviral therapy among people living with HIV/AIDS in Brazilian municipalities between 2019 and 2022
Revista Brasileira de Epidemiologia · 2025
DOI: 10.1590/1980-549720250015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Brasileira de Epidemiologia, 2025. Verfasst von Ana Paula da Cunha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Fundação Oswaldo Cruz, Sergio Arouca National School of Public Health - Rio de Janeiro (RJ), Brazil. Hauptthemen laut MEDLINE: HIV Infections, Acquired Immunodeficiency Syndrome, Anti-HIV Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To analyze the factors associated with antiretroviral therapy interruption among people living with the human immunodeficiency virus participating in the A Hora é Agora [The Time is Now] project in the municipalities of Campo Grande, Curitiba, and Florianópolis.
Methods
This is a cross-sectional analytical study using data from the Brazilian Medication Logistics Control System, collected between October 2019 and September 2022. Bivariate analyses were performed to assess associations between sex, age group, race/skin color, and level of education, with the outcomes of treatment interruption and the number of times the treatment was interrupted, using the χ2 test with a 5% significance level.
Results
In Campo Grande, treatment interruption was more frequent among individuals with eight to 11 years of formal education (34.0%). In Curitiba, women (20.4%) showed a higher frequency of treatment interruption, and the age group of 50 years or older had a higher likelihood of treatment interruption (OR: 1.73; 95%CI: 1.12-2.66). In Florianópolis, 31.1% of women experienced treatment interruption, and individuals with up to seven years of formal education had a higher likelihood of treatment interruption (OR: 1.62; 95%CI: 1.15-2.29).
Conclusions
The interruption of antiretroviral therapy was significantly associated with sex, level of education, and age group, with distinct patterns across the analyzed territorial contexts. These findings highlight the need for targeted interventions aimed at vulnerable groups, considering regional differences and local challenges to improve treatment adherence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fundação Oswaldo Cruz, Sergio Arouca National School of Public Health - Rio de Janeiro (RJ), Brazil.
- Fundação Oswaldo Cruz, Institute of Scientific and Technological Communication and Information on Health - Rio de Janeiro (RJ), Brazil.
- Secretaria Municipal da Saúde de Curitiba - Curitiba (PR), Brazil.
- Secretaria Municipal de Saúde de Campo Grande - Campo Grande (MS), Brazil.
- Secretaria Municipal de Saúde de Florianópolis - Florianópolis (SC), Brazil.
Zitieren
APA
Cunha, A. P. D., Mota, J. C. D., Cruz, M. M. D., Miranda, R., Rosso, L., Kruppa, M., Santos, J., Silva, A. S. P. D., Faccin, G., Schweitzer, C., Zonta, R., & Cota, V. L. (2025). Factors associated with the interruption of antiretroviral therapy among people living with HIV/AIDS in Brazilian municipalities between 2019 and 2022. Revista Brasileira de Epidemiologia. https://doi.org/10.1590/1980-549720250015
Vancouver
Cunha APD, Mota JCD, Cruz MMD, Miranda R, Rosso L, Kruppa M, et al. Factors associated with the interruption of antiretroviral therapy among people living with HIV/AIDS in Brazilian municipalities between 2019 and 2022. Revista Brasileira de Epidemiologia. 2025. doi:10.1590/1980-549720250015
BibTeX
@article{Cunha2025,
author = {Cunha, Ana Paula da and Mota, Jurema Corrêa da and Cruz, Marly Marques da and Miranda, Raquel and Rosso, Liza and Kruppa, Mariele and Santos, Juliane and Silva, Andreia Souza Pinto da and Faccin, Giordana and Schweitzer, Caroline and Zonta, Ronaldo and Cota, Vanda Lúcia},
title = {Factors associated with the interruption of antiretroviral therapy among people living with HIV/AIDS in Brazilian municipalities between 2019 and 2022},
journal = {Revista Brasileira de Epidemiologia},
year = {2025},
doi = {10.1590/1980-549720250015}
}
EUVIMED